Verrica reports high response rate in skin cancer study
WEST CHESTER, Pa. - Verrica Pharmaceuticals Inc. (NASDAQ:VRCA), a small-cap pharmaceutical company ($61.34M market cap) ...
Diabetes drug metformin linked to reduced skin cancer risk
A popular diabetes drug may provide protection against skin cancers, a new study says. Metformin significantly reduces people ...
Knowridge6 天
Diabetes drug metformin may help protect against common skin cancers
A recent study suggests that metformin, a widely prescribed medication for type 2 diabetes, may reduce the risk of developing ...
technologynetworks6 天
Metformin Linked to Protection Against Skin Cancer, Study Finds
Metformin, widely prescribed for type 2 diabetes, may also protect against the two most common types of skin cancer.
Managed Healthcare Executive4 天
The Good and Bad About Melanoma
Five-year survival rates improved greatly because of immunotherapy and other advances, according to the American Cancer ...
Healio9 天
Last patient completes follow-up for phase 3 study of Ameluz-PDT for basal cell carcinoma
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Ameluz is a topical currently indicated for the ...
BioSpace7 天
Where Keytruda Failed, Regeneron Touts Phase III Skin Cancer Win for Libtayo
The positive trial results could help Regeneron cushion the blow of its disappointing fourth-quarter sales for Eylea, which ...